Background: Dietary and herbal supplements (DHS) have a widespread use in Albania, however, there is limited information on the reporting of their adverse effects by pharmacists and patients. This study aims to assess the reporting of suspected adverse reactions for dietary and herbal supplements by pharmacists and patients in Albania, as well as to evaluate the recurrence and occurrence of these reactions. Methods: A questionnaire-based survey was distributed online in Albania from January 2024 to March 2024 to patients and pharmacists with experience in direct patient care to evaluate their knowledge of the signaling of suspected adverse reactions of DHS. Results: A total of 113 pharmacists, and 159 patients in 9 and 12 different cities in Albania, respectively, consented to participate in the study. 69.91% of the pharmacists reported being informed about the necessity of reporting adverse effects associated with DHS during national conferences. However, only 8.85% have reported such effects to the responsible importers. Only 5.66% of patients have reported to their pharmacists about the adverse reactions of those products. Conclusions: The study highlights the need for improved education and training on reporting procedures for pharmacists and patients in Albania. By enhancing pharmacovigilance practices and promoting awareness among pharmacists and patients, we can lead toward a safer healthcare system in Albania. © 2025 by authors, all rights reserved.
A Questionnaire-based Survey of the Suspected Adverse Reactions Reporting Associated with Dietary and Herbal Supplements by Pharmacists and Patients in Albania
Hoxha, M.
;Malaj, V.;Firza, Najada.
2024-01-01
Abstract
Background: Dietary and herbal supplements (DHS) have a widespread use in Albania, however, there is limited information on the reporting of their adverse effects by pharmacists and patients. This study aims to assess the reporting of suspected adverse reactions for dietary and herbal supplements by pharmacists and patients in Albania, as well as to evaluate the recurrence and occurrence of these reactions. Methods: A questionnaire-based survey was distributed online in Albania from January 2024 to March 2024 to patients and pharmacists with experience in direct patient care to evaluate their knowledge of the signaling of suspected adverse reactions of DHS. Results: A total of 113 pharmacists, and 159 patients in 9 and 12 different cities in Albania, respectively, consented to participate in the study. 69.91% of the pharmacists reported being informed about the necessity of reporting adverse effects associated with DHS during national conferences. However, only 8.85% have reported such effects to the responsible importers. Only 5.66% of patients have reported to their pharmacists about the adverse reactions of those products. Conclusions: The study highlights the need for improved education and training on reporting procedures for pharmacists and patients in Albania. By enhancing pharmacovigilance practices and promoting awareness among pharmacists and patients, we can lead toward a safer healthcare system in Albania. © 2025 by authors, all rights reserved.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.